Sign in

CIK 0001689375

  • Accelerated filer
  • Smaller reporting company
  • Emerging growth company

Entrada Therapeutics, Inc.

Sign in to watch
Ticker
TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813983399
Phone
+1 857-305-1825
Business address
ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
Former names
CycloPorters, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy Director bought 5,000 shares at $5.86 ($29,316)
  4. 4 Planned sale President, Research & Develop. sold 25,907 shares at $15.39 ($398,810)
  5. 4 Planned sale President & COO sold 15,000 shares at $15.33 ($229,953)
  6. 4 Planned sale Chief Financial Officer sold 2,500 shares at $12.95 ($32,375)
  7. 4 Planned sale President & COO sold 15,010 shares at an average $13.04 ($195,771)
  8. 4 Planned sale Chief Financial Officer sold 16,477 shares at an average $13.01 ($214,379)
  9. 4 Planned sale Chief Financial Officer sold 7,988 shares at $12.25 ($97,892)
  10. 4 Shares withheld for taxes CEO gave up 29,050 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Financial Officer gave up 8,651 shares (to pay taxes)
  12. 4 Shares withheld for taxes President & COO gave up 21,261 shares (to pay taxes)
  13. 4 Shares withheld for taxes President, Research & Develop. gave up 11,475 shares (to pay taxes)
  14. 4 Planned sale Chief Financial Officer sold 8,910 shares at $9.98 ($88,932)
  15. 4 Open-market buy 10% owner bought 28,867 shares at an average $9.07 ($261,846)
  16. 4 Open-market sale Director sold 200,000 shares at $8.80 ($1,760,000)
  17. 4 Open-market sale 10% owner sold 200,000 shares at $8.80 ($1,760,000)
  18. 4 Open-market buy 10% owner bought 178,044 shares at an average $7.60 ($1,352,587)
  19. 4 Shares withheld for taxes CEO gave up 8,723 shares (to pay taxes)
  20. 4 Shares withheld for taxes President & COO gave up 1,746 shares (to pay taxes)

Page 2 of 13 · 242 filings